Citadel Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-2,250
Closed -$55.4K – 14598
2024
Q4
$55.4K Sell
2,250
-75
-3% -$3.27K ﹤0.01% 12288
2024
Q3
$125K Buy
+2,325
New +$124K ﹤0.01% 10814
2023
Q2
– Sell
-25
Closed -$1.26K – 14436
2023
Q1
$1.26K Buy
+25
New +$1.48K ﹤0.01% 14334

Other funds holding CNBS

Citadel Advisors's CNBS Position: Q2 2026 in Review

Citadel Advisors increased its Amplify Seymour Cannabis ETF (CNBS) stake by 27% in Q2 2026, buying an estimated $109K and bringing the position to 18,751 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #9627.

Citadel Advisors first reported a position in CNBS in Q2 2021 and has held it in 6 quarters since. 16 funds tracked by Wall St. Rank hold CNBS as of Q2 2026.

  • Citadel Advisors held 18,751 shares of Amplify Seymour Cannabis ETF worth $548K as of Q2 2026.
  • Citadel Advisors bought 3,963 Amplify Seymour Cannabis ETF shares in Q2 2026, an estimated $109K.
  • Amplify Seymour Cannabis ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9627 holding.
  • Citadel Advisors first reported a position in Amplify Seymour Cannabis ETF in Q2 2021 and has held it in 6 quarters since.
  • 16 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.